152 related articles for article (PubMed ID: 25255220)
1. AML cells carrying NPM1 mutation are resistant to nucleophosmin displacement from nucleoli caused by the G-quadruplex ligand TmPyP4.
De Cola A; Pietrangelo L; Forlì F; Barcaroli D; Budani MC; Graziano V; Protasi F; Di Ilio C; De Laurenzi V; Federici L
Cell Death Dis; 2014 Sep; 5(9):e1427. PubMed ID: 25255220
[No Abstract] [Full Text] [Related]
2. Nucleophosmin mutations alter its nucleolar localization by impairing G-quadruplex binding at ribosomal DNA.
Chiarella S; De Cola A; Scaglione GL; Carletti E; Graziano V; Barcaroli D; Lo Sterzo C; Di Matteo A; Di Ilio C; Falini B; Arcovito A; De Laurenzi V; Federici L
Nucleic Acids Res; 2013 Mar; 41(5):3228-39. PubMed ID: 23328624
[TBL] [Abstract][Full Text] [Related]
3. Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.
Nabbouh AI; Hleihel RS; Saliba JL; Karam MM; Hamie MH; Wu HJM; Berthier CP; Tawil NM; Bonnet PA; Deleuze-Masquefa C; El Hajj HA
Cancer; 2017 May; 123(9):1662-1673. PubMed ID: 28055106
[TBL] [Abstract][Full Text] [Related]
4. Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization.
Federici L; Falini B
Protein Sci; 2013 May; 22(5):545-56. PubMed ID: 23436734
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
Falini B; Gionfriddo I; Cecchetti F; Ballanti S; Pettirossi V; Martelli MP
Blood Rev; 2011 Nov; 25(6):247-54. PubMed ID: 21724308
[TBL] [Abstract][Full Text] [Related]
6. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
[TBL] [Abstract][Full Text] [Related]
7. Nucleophosmin 1 Mutations in Acute Myeloid Leukemia.
Zarka J; Short NJ; Kanagal-Shamanna R; Issa GC
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32545659
[TBL] [Abstract][Full Text] [Related]
8. Nucleophosmin C-terminal leukemia-associated domain interacts with G-rich quadruplex forming DNA.
Federici L; Arcovito A; Scaglione GL; Scaloni F; Lo Sterzo C; Di Matteo A; Falini B; Giardina B; Brunori M
J Biol Chem; 2010 Nov; 285(48):37138-49. PubMed ID: 20858903
[TBL] [Abstract][Full Text] [Related]
9. NPM1 ablation induces HSC aging and inflammation to develop myelodysplastic syndrome exacerbated by p53 loss.
Morganti C; Ito K; Yanase C; Verma A; Teruya-Feldstein J; Ito K
EMBO Rep; 2022 May; 23(5):e54262. PubMed ID: 35229971
[TBL] [Abstract][Full Text] [Related]
10. Structural consequences of nucleophosmin mutations in acute myeloid leukemia.
Grummitt CG; Townsley FM; Johnson CM; Warren AJ; Bycroft M
J Biol Chem; 2008 Aug; 283(34):23326-32. PubMed ID: 18511415
[TBL] [Abstract][Full Text] [Related]
11. New insights into the biology of acute myeloid leukemia with mutated NPM1.
Brunetti L; Gundry MC; Goodell MA
Int J Hematol; 2019 Aug; 110(2):150-160. PubMed ID: 30632059
[TBL] [Abstract][Full Text] [Related]
12. AML-associated mutation of nucleophosmin compromises its interaction with nucleolin.
Šašinková M; Holoubek A; Otevřelová P; Kuželová K; Brodská B
Int J Biochem Cell Biol; 2018 Oct; 103():65-73. PubMed ID: 30130654
[TBL] [Abstract][Full Text] [Related]
13. Recognition of intermolecular G-quadruplexes by full length nucleophosmin. Effect of a leukaemia-associated mutation.
Bañuelos S; Lectez B; Taneva SG; Ormaza G; Alonso-Mariño M; Calle X; Urbaneja MA
FEBS Lett; 2013 Jul; 587(14):2254-9. PubMed ID: 23742937
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.
Falini B
Cancer Treat Res; 2010; 145():149-68. PubMed ID: 20306250
[TBL] [Abstract][Full Text] [Related]
15. A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.
Bolli N; De Marco MF; Martelli MP; Bigerna B; Pucciarini A; Rossi R; Mannucci R; Manes N; Pettirossi V; Pileri SA; Nicoletti I; Falini B
Leukemia; 2009 Mar; 23(3):501-9. PubMed ID: 19005479
[TBL] [Abstract][Full Text] [Related]
16. Interactions of the natural product (+)-avrainvillamide with nucleophosmin and exportin-1 Mediate the cellular localization of nucleophosmin and its AML-associated mutants.
Mukherjee H; Chan KP; Andresen V; Hanley ML; Gjertsen BT; Myers AG
ACS Chem Biol; 2015 Mar; 10(3):855-63. PubMed ID: 25531824
[TBL] [Abstract][Full Text] [Related]
17. Two novel NPM1 mutations in a therapy-responder AML patient.
Pianta A; Fabbro D; Damiani D; Tiribelli M; Fanin R; Franzoni A; Romanello M; Tell G; Di Loreto C; Damante G
Hematol Oncol; 2010 Sep; 28(3):151-5. PubMed ID: 19593743
[TBL] [Abstract][Full Text] [Related]
18. Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology.
Vascotto C; Lirussi L; Poletto M; Tiribelli M; Damiani D; Fabbro D; Damante G; Demple B; Colombo E; Tell G
Oncogene; 2014 May; 33(22):2876-87. PubMed ID: 23831574
[TBL] [Abstract][Full Text] [Related]
19. Nucleophosmin, a multifunctional nucleolar organizer with a role in DNA repair.
López DJ; Rodríguez JA; Bañuelos S
Biochim Biophys Acta Proteins Proteom; 2020 Dec; 1868(12):140532. PubMed ID: 32853771
[TBL] [Abstract][Full Text] [Related]
20. Can cytoplasmic nucleophosmin be detected by immunocytochemical staining of cell smears in acute myeloid leukemia?
Mattsson G; Turner SH; Cordell J; Ferguson DJ; Schuh A; Grimwade LF; Bench AJ; Weinberg OK; Marafioti T; George TI; Arber DA; Erber WN; Mason DY
Haematologica; 2010 Apr; 95(4):670-3. PubMed ID: 20015883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
